Abstract
Preview
Dear Editor,
We read with interest the paper by Schiavoni et al.1 on their experience of the use of dabigatran and rivaroxaban, recently published in this Journal. Notably, after a 1-year follow up of 178 patients with non-valvular atrial fibrillation, the authors observed a 3-fold increase in the incidence of non-haemorrhagic complications in the dabigatran group. With this background, we would like to report on acute agranulocytosis after oral administration of dabigatran. [ ... ]
Downloads
- Abstract viewed - 206 times
- PDF downloaded - 45 times